Anticancer Activity of Erianin: Cancer-Specific Target Prediction Based on Network Pharmacology
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anticancer Activity of Erianin: Cancer-Specific Target Prediction Based on Network Pharmacology
Authors
Keywords
-
Journal
Frontiers in Molecular Biosciences
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-03-17
DOI
10.3389/fmolb.2022.862932
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Traditional uses, chemical constituents, pharmacological activities, and toxicological effects of Dendrobium leaves: A review
- (2021) Yue-Hu Wang JOURNAL OF ETHNOPHARMACOLOGY
- Pancancer survival analysis of cancer hallmark genes
- (2021) Ádám Nagy et al. Scientific Reports
- Identification of NQO2 As a Protein Target in Small Molecule Modulation of Hepatocellular Function
- (2021) Arnout G. Schepers et al. ACS Chemical Biology
- Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway
- (2021) Yonggang Xu et al. BIOSCIENCE REPORTS
- Erianin inhibits human lung cancer cell growth via PI3K /Akt/ mTOR pathway in vitro and in vivo
- (2021) Hui‐qiong Zhang et al. PHYTOTHERAPY RESEARCH
- Predictive Value of the TP53/PIK3CA/ATM Mutation Classifier for Patients With Bladder Cancer Responding to Immune Checkpoint Inhibitor Therapy
- (2021) Yi-Hui Pan et al. Frontiers in Immunology
- Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification
- (2021) Yan Wang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Natural Product Erianin Inhibits Bladder Cancer Cell Growth by Inducing Ferroptosis via NRF2 Inactivation
- (2021) Yu Xiang et al. Frontiers in Pharmacology
- Erianin: A Direct NLRP3 Inhibitor With Remarkable Anti-Inflammatory Activity
- (2021) Xinyong Zhang et al. Frontiers in Immunology
- Erianin Induces Apoptosis and Autophagy in Oral Squamous Cell Carcinoma Cells
- (2020) Yi-Tzu Chen et al. AMERICAN JOURNAL OF CHINESE MEDICINE
- Erianin suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK MAPK signaling pathways
- (2020) Liang Yang et al. BIOSCIENCE REPORTS
- Anti-inflammation of Erianin in dextran sulphate sodium-induced ulcerative colitis mice model via collaborative regulation of TLR4 and STAT3
- (2020) Bo Dou et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Global PROTAC Toolbox for Degrading BCR–ABL Overcomes Drug-Resistant Mutants and Adverse Effects
- (2020) Yiqing Yang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dual Targeting of Cell Growth and Phagocytosis by Erianin for Human Colorectal Cancer
- (2020) Yihan Sun et al. Drug Design Development and Therapy
- Curcumol Overcomes TRAIL Resistance of Non‐Small Cell Lung Cancer by Targeting NRH:Quinone Oxidoreductase 2 (NQO2)
- (2020) Jing Zhang et al. Advanced Science
- Erianin inhibits the oncogenic properties of hepatocellular carcinoma via inducing DNA damage and aberrant mitosis
- (2020) Heng Dong et al. BIOCHEMICAL PHARMACOLOGY
- Synergistic cytotoxicity of erianin, a bisbenzyl in the dietetic Chinese herb Dendrobium against breast cancer cells
- (2020) Hualing Xie et al. FOOD AND CHEMICAL TOXICOLOGY
- Erianin regulates programmed cell death ligand 1 expression and enhances cytotoxic T lymphocyte activity
- (2020) Ao Yang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Targeting FLT3 mutations in AML: review of current knowledge and evidence
- (2019) Naval Daver et al. LEUKEMIA
- A Simple Method for the Screening and Measurement of Phenols in Dendrobium chrysotoxum by a Miniature Mass Detector Using a Matrix Solid-Phase Dispersion Method
- (2019) Hongcheng Liu et al. Journal of Analytical Methods in Chemistry
- Erianin protects against high glucose-induced oxidative injury in renal tubular epithelial cells
- (2019) Mei-Fen Chen et al. FOOD AND CHEMICAL TOXICOLOGY
- SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules
- (2019) Antoine Daina et al. NUCLEIC ACIDS RESEARCH
- Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits bladder cancer cell growth via the mitochondrial apoptosis and JNK pathways
- (2019) Qiyu Zhu et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Progressive study of effects of erianin on anticancer activity
- (2019) Yuying Zhang et al. OncoTargets and Therapy
- The anti-carcinogenesis properties of erianin in the modulation of oxidative stress-mediated apoptosis and immune response in liver cancer
- (2019) Xinrui Zhang et al. Aging-US
- Discovery of potent 4-aminoquinoline hydrazone inhibitors of NRH:quinoneoxidoreductase-2 (NQO2)
- (2019) Buthaina Hussein et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Clinical and Translational Implications of RET Rearrangements in Non–Small Cell Lung Cancer
- (2018) Roberto Ferrara et al. Journal of Thoracic Oncology
- Targeting the NLRP3 inflammasome in inflammatory diseases
- (2018) Matthew S. J. Mangan et al. NATURE REVIEWS DRUG DISCOVERY
- CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest
- (2018) Shom Goel et al. TRENDS IN CELL BIOLOGY
- Erianin inhibits human cervical cancer cell through regulation of tumor protein p53 via the extracellular signal‑regulated kinase signaling pathway
- (2018) Mengting Li et al. Oncology Letters
- FLT3 inhibitors in acute myeloid leukemia
- (2018) Mei Wu et al. Journal of Hematology & Oncology
- Erianin induces cell apoptosis through ERK pathway in human nasopharyngeal carcinoma
- (2018) Yen-Tze Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer
- (2017) Emil Christensen et al. EUROPEAN UROLOGY
- High expression of FLT3 is a risk factor in leukemia
- (2017) Jie Cheng et al. Molecular Medicine Reports
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma
- (2017) Song Ye et al. ONCOLOGY REPORTS
- A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma
- (2016) Cristina Romei et al. Nature Reviews Endocrinology
- Erianin induces G2/M-phase arrest, apoptosis and autophagy via the ROS/JNK signaling pathway in human osteosarcoma cells in vitro and in vivo
- (2016) H Wang et al. Cell Death & Disease
- Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells
- (2016) Maryam Abbaspour Babaei et al. Drug Design Development and Therapy
- Mutation and prognostic analyses of PIK3CA in patients with completely resected lung adenocarcinoma
- (2016) Zhengbo Song et al. Cancer Medicine
- Erianin inhibits high glucose-induced retinal angiogenesis via blocking ERK1/2-regulated HIF-1α-VEGF/VEGFR2 signaling pathway
- (2016) Zengyang Yu et al. Scientific Reports
- Signaling Intermediates (MAPK and PI3K) as Therapeutic Targets in NSCLC
- (2014) Ludovica Ciuffreda et al. CURRENT PHARMACEUTICAL DESIGN
- OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders
- (2014) Joanna S. Amberger et al. NUCLEIC ACIDS RESEARCH
- PI3K/AKT pathway activation in bladder carcinogenesis
- (2013) Julien Calderaro et al. INTERNATIONAL JOURNAL OF CANCER
- PIK3CA gene mutation associated with poor prognosis of lung adenocarcinoma
- (2013) Wentao Yue et al. OncoTargets and Therapy
- Apoptosis in cancer: from pathogenesis to treatment
- (2011) Rebecca SY Wong JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance
- (2009) Thomas O'Hare et al. CANCER CELL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started